vs
AdvanSix Inc.（ASIX）与MEDICAL PROPERTIES TRUST INC（MPW）财务数据对比。点击上方公司名可切换其他公司
AdvanSix Inc.的季度营收约是MEDICAL PROPERTIES TRUST INC的1.3倍（$359.9M vs $270.3M），MEDICAL PROPERTIES TRUST INC净利率更高（6.5% vs -0.8%，领先7.3%），MEDICAL PROPERTIES TRUST INC同比增速更快（16.6% vs 9.4%），过去两年AdvanSix Inc.的营收复合增速更高（3.4% vs -0.2%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Medical Properties Trust, Inc.（MPT）是一家总部位于美国阿拉巴马州伯明翰的跨国房地产投资信托基金（REIT），主要在美欧地区收购、投资医疗保健设施与营利性医疗控股公司，资产收购多采用售后回租模式，原业主出售资产后成为其租户，租户通常需签署长期三净租赁协议。
ASIX vs MPW — 直观对比
营收规模更大
ASIX
是对方的1.3倍
$270.3M
营收增速更快
MPW
高出7.2%
9.4%
净利率更高
MPW
高出7.3%
-0.8%
两年增速更快
ASIX
近两年复合增速
-0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $270.3M |
| 净利润 | $-2.8M | $17.6M |
| 毛利率 | 7.6% | 95.8% |
| 营业利润率 | -0.7% | 9.7% |
| 净利率 | -0.8% | 6.5% |
| 营收同比 | 9.4% | 16.6% |
| 净利润同比 | -892.9% | 104.3% |
| 每股收益（稀释后） | $-0.11 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXMPW
| Q4 25 | $359.9M | $270.3M | ||
| Q3 25 | $374.5M | $237.5M | ||
| Q2 25 | $410.0M | $240.4M | ||
| Q1 25 | $377.8M | $223.8M | ||
| Q4 24 | $329.1M | $231.8M | ||
| Q3 24 | $398.2M | $225.8M | ||
| Q2 24 | $453.5M | $266.6M | ||
| Q1 24 | $336.8M | $271.3M |
净利润ASIXMPW
| Q4 25 | $-2.8M | $17.6M | ||
| Q3 25 | $-2.6M | $-77.7M | ||
| Q2 25 | $31.4M | $-98.4M | ||
| Q1 25 | $23.3M | $-118.3M | ||
| Q4 24 | $352.0K | $-412.3M | ||
| Q3 24 | $22.3M | $-801.2M | ||
| Q2 24 | $38.9M | $-320.6M | ||
| Q1 24 | $-17.4M | $-875.6M |
毛利率ASIXMPW
| Q4 25 | 7.6% | 95.8% | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | 91.8% | ||
| Q1 25 | 14.2% | 63.6% | ||
| Q4 24 | 3.4% | 90.9% | ||
| Q3 24 | 14.4% | 96.5% | ||
| Q2 24 | 17.9% | 98.4% | ||
| Q1 24 | 0.9% | 84.9% |
营业利润率ASIXMPW
| Q4 25 | -0.7% | 9.7% | ||
| Q3 25 | -0.9% | -28.0% | ||
| Q2 25 | 7.7% | -36.7% | ||
| Q1 25 | 7.7% | -48.5% | ||
| Q4 24 | -3.9% | -173.7% | ||
| Q3 24 | 7.5% | -350.7% | ||
| Q2 24 | 11.5% | -114.5% | ||
| Q1 24 | -7.0% | -318.6% |
净利率ASIXMPW
| Q4 25 | -0.8% | 6.5% | ||
| Q3 25 | -0.7% | -32.7% | ||
| Q2 25 | 7.7% | -40.9% | ||
| Q1 25 | 6.2% | -52.8% | ||
| Q4 24 | 0.1% | -177.8% | ||
| Q3 24 | 5.6% | -354.8% | ||
| Q2 24 | 8.6% | -120.3% | ||
| Q1 24 | -5.2% | -322.7% |
每股收益（稀释后）ASIXMPW
| Q4 25 | $-0.11 | $0.03 | ||
| Q3 25 | $-0.10 | $-0.13 | ||
| Q2 25 | $1.15 | $-0.16 | ||
| Q1 25 | $0.86 | $-0.20 | ||
| Q4 24 | $0.02 | $-0.68 | ||
| Q3 24 | $0.82 | $-1.34 | ||
| Q2 24 | $1.43 | $-0.54 | ||
| Q1 24 | $-0.65 | $-1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $540.9M |
| 总债务越低越好 | — | $9.7B |
| 股东权益账面价值 | $815.2M | $4.6B |
| 总资产 | $1.7B | $15.0B |
| 负债/权益比越低杠杆越低 | — | 2.11× |
8季度趋势，按日历期对齐
现金及短期投资ASIXMPW
| Q4 25 | $19.8M | $540.9M | ||
| Q3 25 | $23.7M | $396.6M | ||
| Q2 25 | $18.4M | $509.8M | ||
| Q1 25 | $8.3M | $673.5M | ||
| Q4 24 | $19.6M | $332.3M | ||
| Q3 24 | $17.3M | $275.6M | ||
| Q2 24 | $12.1M | $606.5M | ||
| Q1 24 | $20.6M | $224.3M |
总债务ASIXMPW
| Q4 25 | — | $9.7B | ||
| Q3 25 | — | $9.6B | ||
| Q2 25 | — | $9.6B | ||
| Q1 25 | — | $9.5B | ||
| Q4 24 | — | $8.8B | ||
| Q3 24 | — | $9.2B | ||
| Q2 24 | — | $9.4B | ||
| Q1 24 | — | $10.1B |
股东权益ASIXMPW
| Q4 25 | $815.2M | $4.6B | ||
| Q3 25 | $818.2M | $4.7B | ||
| Q2 25 | $823.7M | $4.8B | ||
| Q1 25 | $794.4M | $4.8B | ||
| Q4 24 | $774.6M | $4.8B | ||
| Q3 24 | $766.4M | $5.4B | ||
| Q2 24 | $746.6M | $6.2B | ||
| Q1 24 | $713.2M | $6.7B |
总资产ASIXMPW
| Q4 25 | $1.7B | $15.0B | ||
| Q3 25 | $1.7B | $14.9B | ||
| Q2 25 | $1.6B | $15.2B | ||
| Q1 25 | $1.6B | $14.9B | ||
| Q4 24 | $1.6B | $14.3B | ||
| Q3 24 | $1.5B | $15.2B | ||
| Q2 24 | $1.5B | $16.2B | ||
| Q1 24 | $1.5B | $17.3B |
负债/权益比ASIXMPW
| Q4 25 | — | 2.11× | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | 2.00× | ||
| Q1 25 | — | 1.99× | ||
| Q4 24 | — | 1.83× | ||
| Q3 24 | — | 1.69× | ||
| Q2 24 | — | 1.51× | ||
| Q1 24 | — | 1.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $230.8M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | 13.11× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
经营现金流ASIXMPW
| Q4 25 | $63.7M | $230.8M | ||
| Q3 25 | $26.6M | $18.6M | ||
| Q2 25 | $21.1M | $51.7M | ||
| Q1 25 | $11.4M | $384.0K | ||
| Q4 24 | $64.2M | $245.5M | ||
| Q3 24 | $57.3M | $59.2M | ||
| Q2 24 | $50.2M | $35.3M | ||
| Q1 24 | $-36.2M | $74.3M |
自由现金流ASIXMPW
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
自由现金流率ASIXMPW
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
资本支出强度ASIXMPW
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
现金转化率ASIXMPW
| Q4 25 | — | 13.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
MPW
暂无分部数据
